Noncoding RNAs as Novel Biomarkers in Pancreatic Cancer: What Do We Know?

Future Oncology - United Kingdom
doi 10.2217/fon-2016-0253
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2016English

Incidental Pancreatic Cysts: Do We Really Know What We Are Watching?

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2010English

Quasicrystals. What Do We Know – What Can We Know?

Acta Crystallographica Section A: Foundations and Advances
Materials ScienceCondensed Matter PhysicsTheoretical ChemistryBiochemistryStructural BiologyInorganic ChemistryPhysical
2017English

Medical Financial Hardship Among Cancer Survivors in the United States: What Do We Know? What Do We Need to Know?

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

Psychosomatic and Psychosocial Questions Regarding Bariatric Surgery: What Do We Know, or What Do We Think We Know?

Zeitschrift fur Psychosomatische Medizin und Psychotherapie
MedicineClinical PsychologyPsychiatryApplied PsychologyMental Health
2017English

What Do We Know About Vision?

Journal of Applied Business Research
International ManagementBusiness
2011English

What Do We Know About Neuromarketing?

Journal of Advertising Research
CommunicationMarketing
2019English

How Do We “Know” What Our Students “Know” They “Know”?

US-China Education Review B
2019English

What Do We Know About Entrepreneurship as an Intangible Asset?

International Journal of Entrepreneurship and Small Business
EconomicsInternational ManagementBusinessEconometrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy